Survival and contralateral breast cancer in CHEK2 1100delC breast cancer patients: impact of adjuvant chemotherapy

BACKGROUND: We assessed the sensitivity to adjuvant chemotherapy in cell cycle checkpoint kinase 2 (CHEK2) vs non-CHEK2 breast cancer patients by comparing the contralateral breast cancer incidence and distant disease-free and breast cancer-specific survival between both groups, stratified for adjuv...

Descripción completa

Detalles Bibliográficos
Autores principales: Kriege, M, Hollestelle, A, Jager, A, Huijts, P E A, Berns, E M, Sieuwerts, A M, Meijer-van Gelder, M E, Collée, J M, Devilee, P, Hooning, M J, Martens, J W M, Seynaeve, C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4150261/
https://www.ncbi.nlm.nih.gov/pubmed/24918820
http://dx.doi.org/10.1038/bjc.2014.306

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4150261/
https://www.ncbi.nlm.nih.gov/pubmed/24918820
http://dx.doi.org/10.1038/bjc.2014.306

Ejemplares similares